Perfect Medical Health Management (1830) H1 2026 earnings summary

Executive summary

• Revenue for the six months ended 30 September 2025 was HK$485.9 million, down 21.7% year-over-year, but the pace of decline slowed and profit rebounded 43.4% from the previous half-year, driven by cost control and service mix optimization.

• Profit attributable to equity holders was HK$94.8 million, down 32.7% year-over-year but up from HK$66.1 million in the prior six months.

• The Group maintained a 100%+ dividend payout ratio for the eleventh consecutive year, with a 101.3% payout for the period.

Financial highlights

• EBITDA for the period was HK$142.2 million, down 26.7% year-over-year, with an EBITDA margin of 29.3%.

• Operating profit dropped 30.0% to HK$111.0 million, with an operating margin of 22.8%.

• Net profit margin was 19.5%, compared to 22.7% in the prior year period.

• Basic earnings per share were HK7.5 cents, down from HK11.2 cents year-over-year.

• Interim dividend of HK7.6 cents per share declared, representing a payout ratio of 101.3%.

Outlook and guidance

• The Group is confident about the outlook for the second half of FY2026, with key profitability drivers improving and a leaner cost base supporting future earnings.

• Strategic focus remains on high-margin aesthetic medical services, digitalization, and membership ecosystem enhancement, with continued investment in AI-driven marketing and expansion of Oracle and Goku Spa offerings.